Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: J&J | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: J&J

Worldwide Pharmaceutical sales were $22.4 billion for the year (-1%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

J&J

4Q Revenues: $15.6 billion (-6%)

4Q Earnings: $1.9 billion (-12%)

FY Revenues: $61.6 billion (-1%)

FY Earnings: $13.3 billion (+9%)

Comments: Worldwide Pharmaceutical sales were $22.4 billion for the year (-1%). Domestic sales were down 4% and international sales increased 4%. Worldwide Consumer sales were $14.6 billion for the year (-8%). Domestic sales of that unit decreased 19% for the year and 29% for 4Q10, while international sales increased 1% for the year but dropped 6% for the quarter. Consumer sales were impacted by numerous recalls of OTC medicines and the suspension of manufacturing at the McNeil Consumer Healthcare facility in Fort Washington, PA. Overall, consumer sales fell $1.2 billion for the year. Worldwide Medical Devices and Diagnostics sales were $24.6 billion for the year (+4%). Results in the quarter included after-tax charges of $922 million for litigation settlements, product liability expense and costs associated with the DePuy ASR Hip recall. Earnings in 2009 included an after-tax restructuring charge of $852 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters